Articles tagged with “insilico-medicine”

INS018_055 Phase IIa Results: First AI-Designed Drug

Analyze the Phase IIa clinical trial results of INS018_055 (rentosertib), the first AI-designed drug by Insilico Medicine targeting TNIK for IPF treatment.

35 min read

4/19/2026

ai drug discovery ins018_055 rentosertib insilico medicine idiopathic pulmonary fibrosis tnik inhibitor phase 2a trials

Insilico Pharma.AI: AI Drug Discovery Platform Analysis

Analyze Insilico Medicine's Pharma.AI platform for AI drug discovery. Learn how PandaOmics, Chemistry42, and MMAI Gym integrate for target and molecule design.

50 min read

4/16/2026

ai drug discovery insilico medicine pharma.ai pandaomics chemistry42 mmai gym target discovery generative chemistry

AI Drug Discovery: The $2.75B Lilly-Insilico Deal Analysis

Analyze the $2.75B partnership between Eli Lilly and Insilico Medicine. Understand how generative AI impacts pharma R&D strategy and drug commercialization.

45 min read

4/13/2026

ai drug discovery generative ai pharma rd strategy drug commercialization small molecule drugs biopharma partnerships insilico medicine